Europe e-Clinical Solutions Market – Industry Trends and Forecast to 2026

  • Healthcare
  • Published Report
  • Nov 2020
  • Europe
  • 350 Pages
  • No of Tables: 51
  • No of Figures: 26

Europe e-Clinical Solutions Market, By Product {Electronic Clinical Outcome Assessment (ECOA), Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Clinical Trial Management Systems (CTMS), Clinical Analytics Platforms, Randomization and Trial Supply Management (RTSM), Clinical Data Integration Platforms, Safety Solutions, Electronic Trial Master File Systems, Regulatory Information Management Solutions and Other e-Clinical Solutions}, Deployment {Web-Hosted (On-Demand) Solutions, Cloud-Based (SaaS) Solutions and Licensed Enterprise (On-Premise) Solutions}, Clinical Trial Phase (Phase I, Phase II, Phase III and Phase IV), End User {Hospital/Healthcare Provider, Contract Research Organizations (CROS), Pharma & Biotech Organizations, Medical Device Manufacturers, Consulting Service Companies and Academic Institutes}, Country (Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe) Industry Trends and Forecast to 2026

Europe e-Clinical Solutions Market Market Analysis and Insights: Europe e-Clinical Solutions Market

Europe e-Clinical solutions market is expected to gain market growth in the forecast period of 2019 to 2026. Data Bridge Market Research analyses that the market is growing with a CAGR of 12.8% in the forecast period of 2019 to 2026 and expected to reach USD 11,753.08 million by 2026.

e-Clinical solutions are comprised of electronic health record, electronic consent forms, integrating e-Technologies, electronic data capture and clinical data management systems. E-Clinical solutions are helping researchers in end-to-end clinical research process providing solution, through proper management of lengthy clinical research process.

Advancement in technology and government initiatives raises the market of e-Clinical solutions. It helps the clinical research organizations with regulatory document management, team collaboration and management of supply chains, site performance management and reporting which is increasing the demand of e-Clinical solutions in the market in the forecast period.

This Europe e-Clinical solutions market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

 Europe e-Clinical Solutions MarketEurope E-Clinical solutions Market Scope and Market Size

The Europe e-Clinical solutions market is segmented into four notable segments which are product, deployment, clinical trial phase and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product, the Europe e-Clinical solutions market is segmented into electronic clinical outcome assessment (ECOA), electronic data capture (EDC) and clinical data management systems (CDMS), clinical trial management systems (CTMS), clinical analytics platforms, randomization and trial supply management (RTSM), clinical data integration platforms, safety solutions, electronic trial master file systems, regulatory information management solutions and other e-Clinical solutions. In 2019, electronic data capture (EDC) and clinical data management systems (CDMS) segment is expected to dominate the Europe e-Clinical solutions market. This is due to high number of conducting trails, high demand for e-Diaries and clinical studies. Due to these EDC and CDMS product segment is growing and the number of trials are captured in the solution and kept for further examinations.
  • On the basis of deployment, the Europe e-Clinical solutions market is segmented into web-hosted (on-demand) solutions, cloud-based (SaaS) solutions and licensed enterprise (on-premise) solutions. In 2019, web-hosted (on-demand) solutions segment is expected to dominate the Europe e-Clinical solutions market. e-clinical deployment web-hosted (on-demand) solutions are mostly used as they are more reliable and due to security reasons they are mostly preferred. Due to this reason web-hosted (on-demand) solutions segment is growing with the highest.
  • On the basis clinical trial phase, the Europe e-Clinical solutions market is segmented into phase I, phase II, phase III and phase IV. In 2019, Phase III segment is expected to dominate the Europe e-Clinical solutions market. e-clinical solutions phases are most crucial part and phase III accounts for the major portion as the clinical trials are mostly tested in the phase III and once they are cleared for this phase they are headed to further phase and then FDA approvals.
  • On the basis of end user, the Europe e-Clinical solutions market is segmented into hospital/healthcare provider, contract research organizations (CROs), pharma & biotech organizations, medical device manufacturers, consulting service companies and academic institutes. In 2019, Contract research organization (CROs) is dominating the market as the e-Clinical solutions directly examined by the CROs authorities and then then they are supplied to different areas and many customers also trust the CROs for their e-Clinical solutions. Due to this reason there is an increased demand of CROs among the customers.

e-Clinical solutions market Country Level Analysis

The Europe e-Clinical solutions market is segmented into four notable segments which are product, deployment, clinical trial phase and end user.

The countries covered in Europe e-Clinical solutions market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe.

Germany is dominating the Europe as region for e-Clinical solutions market as e-Clinical solutions have helped the doctors and researcher to reduce clinical trial cost, duration and to collect data, to reduce chance of data loss which is increasing the usage of e-Clinical solutions in the U.K. and Italy.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

 Europe e-Clinical Solutions MarketCompetitive Landscape and Europe e-Clinical Solutions Market Share Analysis

Europe e-Clinical solutions market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Europe e-Clinical solutions market.

Some of the major players operating in Europe e-Clinical solutions market are Parexel International Corporation, Oracle, Medidata Solutions, Inc., Veeva Systems, ERT Clinical, IBM Corporation, Bioclinica, ArisGlobal, Anju Software, Inc., Bio-Optronics, Inc., DATATRAK Int., ICON plc, MasterControl, Inc., OmniComm Systems, Inc., RESONANCE HEALTH, Signant Health, Xybion Corporation among others.

  • In September 2019, ERT clinical expands to Heart Health and Research which is focused on raising awareness about the conditions that lead to cardiac arrest. The objective of this expansion is to access cardiac safety with additional support to provide cost efficient screenings to ensure children safety. With this expansion company will increase its business portfolio.

Customization Available : Europe e-Clinical Solutions Market 

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES

TABLE 1 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE

TABLE 2 EUROPEECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 3 EUROPE E-CLINICAL SOLUTIONS  MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 4 EUROPEECLINICAL SOLUTIONSMARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 5 EUROPE E-CLINICAL SOLUTIONS  MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 6 EUROPE E-CLINICAL SOLUTIONS  MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 7 EUROPE E-CLINICAL SOLUTIONS  MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 8 EUROPE E-CLINICAL SOLUTIONS  MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 9 EUROPE E-CLINICAL SOLUTIONS  MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 10 EUROPE E-CLINICAL SOLUTIONS  MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 11 GERMANY ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 12 GERMANY ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 13 GERMANY ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 14 GERMANY ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 15 U.K. ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 16 U.K. ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 17 U.K. ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 18 U.K. ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 19 ITALY ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 20 ITALY ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 21 ITALY ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 22 ITALY ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 23 FRANCE ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 24 FRANCE ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 25 FRANCE ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 26 FRANCE ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 27 RUSSIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 28 RUSSIA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 29 RUSSIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 30 RUSSIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 31 SWITZERLAND ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 32 SWITZERLAND ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 33 SWITZERLAND ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 34 SWITZERLAND ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 35 NETHERLANDS ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 36 NETHERLANDS ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 37 NETHERLANDS ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 38 NETHERLANDS ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 39 SPAIN ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 40 SPAIN ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 41 SPAIN ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 42 SPAIN ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 43 TURKEY ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 44 TURKEY ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 45 TURKEY ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 46 TURKEY ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 47 BELGIUM ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 48 BELGIUM ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 49 BELGIUM ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 50 BELGIUM ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 51 REST OF EUROPE E-CLINICAL SOLUTIONS  MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions